81 related articles for article (PubMed ID: 18056173)
1. Novel markers of subclinical disease for Ewing family tumors from gene expression profiling.
Cheung IY; Feng Y; Danis K; Shukla N; Meyers P; Ladanyi M; Cheung NK
Clin Cancer Res; 2007 Dec; 13(23):6978-83. PubMed ID: 18056173
[TBL] [Abstract][Full Text] [Related]
2. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
3. STAT3 is activated in a subset of the Ewing sarcoma family of tumours.
Lai R; Navid F; Rodriguez-Galindo C; Liu T; Fuller CE; Ganti R; Dien J; Dalton J; Billups C; Khoury JD
J Pathol; 2006 Apr; 208(5):624-32. PubMed ID: 16463269
[TBL] [Abstract][Full Text] [Related]
4. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells.
Riggi N; Cironi L; Provero P; Suvà ML; Kaloulis K; Garcia-Echeverria C; Hoffmann F; Trumpp A; Stamenkovic I
Cancer Res; 2005 Dec; 65(24):11459-68. PubMed ID: 16357154
[TBL] [Abstract][Full Text] [Related]
5. Primary extraskeletal Ewing family tumor with complex epithelial differentiation: a unique case arising in the lateral neck presenting with Horner syndrome.
Weinreb I; Goldstein D; Perez-Ordoñez B
Am J Surg Pathol; 2008 Nov; 32(11):1742-8. PubMed ID: 18769338
[TBL] [Abstract][Full Text] [Related]
6. Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines.
Szuhai K; Ijszenga M; Tanke HJ; Rosenberg C; Hogendoorn PC
Cancer Genet Cytogenet; 2006 Apr; 166(2):173-9. PubMed ID: 16631476
[TBL] [Abstract][Full Text] [Related]
7. [Minimal residual disease in bone marrow in patients with Ewing's sarcoma detected by RT-PCR amplification of EWS-FLI-1 fusion gene transcript].
Tang S; Huang D; Zhang X
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):48-9. PubMed ID: 11776597
[TBL] [Abstract][Full Text] [Related]
8. Ewing Sarcoma tumor cells express CD34: implications for autologous stem cell transplantation.
Yaniv I; Stein J; Luria D; Cohen IJ; Liberzon E; Manor S; Grunshpan A; Sverdlov Y; Kodman Y; Issakov J; Feinmesser M; Zaizov R; Avigad S
Bone Marrow Transplant; 2007 May; 39(10):589-94. PubMed ID: 17369866
[TBL] [Abstract][Full Text] [Related]
9. DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets.
Staege MS; Hutter C; Neumann I; Foja S; Hattenhorst UE; Hansen G; Afar D; Burdach SE
Cancer Res; 2004 Nov; 64(22):8213-21. PubMed ID: 15548687
[TBL] [Abstract][Full Text] [Related]
10. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.
Hu-Lieskovan S; Zhang J; Wu L; Shimada H; Schofield DE; Triche TJ
Cancer Res; 2005 Jun; 65(11):4633-44. PubMed ID: 15930281
[TBL] [Abstract][Full Text] [Related]
11. [Detection of EWS-/FLI-1 gene fusion transcripts by RT-PCR as a tool in the diagnosis of tumors of the Ewing sarcoma group].
Dockhorn-Dworniczak B; Schäfer KL; Dantcheva R; Blasius S; van Valen F; Burdach S; Winkelmann W; Jürgens J; Böcker W
Verh Dtsch Ges Pathol; 1994; 78():214-9. PubMed ID: 7533989
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of HAT-sensitive Ewing tumour cells for immunotherapy.
Pfeifle C; Reinhardt K; Heins S; Burdach S; Staege MS
Anticancer Res; 2009 Nov; 29(11):4489-96. PubMed ID: 20032396
[TBL] [Abstract][Full Text] [Related]
13. The Biology of Ewing sarcoma.
Riggi N; Stamenkovic I
Cancer Lett; 2007 Aug; 254(1):1-10. PubMed ID: 17250957
[TBL] [Abstract][Full Text] [Related]
14. Role of fusion subtype in Ewing sarcoma.
Barr FG; Meyer WH
J Clin Oncol; 2010 Apr; 28(12):1973-4. PubMed ID: 20308653
[No Abstract] [Full Text] [Related]
15. [Minimal metastatic and minimal residual disease in patients with Ewing tumors].
Zoubek A; Pfleiderer C; Ambros PF; Kronberger M; Dworzak MN; Gruber B; Luegmayer A; Windhager R; Fink FM; Urban C
Klin Padiatr; 1995; 207(4):242-7. PubMed ID: 7564161
[TBL] [Abstract][Full Text] [Related]
16. Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types.
Thorner P; Squire J; Chilton-MacNeil S; Marrano P; Bayani J; Malkin D; Greenberg M; Lorenzana A; Zielenska M
Am J Pathol; 1996 Apr; 148(4):1125-38. PubMed ID: 8644855
[TBL] [Abstract][Full Text] [Related]
17. Advances in Ewing's sarcoma research: where are we now and what lies ahead?
Ordóñez JL; Osuna D; Herrero D; de Alava E; Madoz-Gúrpide J
Cancer Res; 2009 Sep; 69(18):7140-50. PubMed ID: 19738075
[TBL] [Abstract][Full Text] [Related]
18. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T
Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222
[TBL] [Abstract][Full Text] [Related]
19. FUS/ERG gene fusions in Ewing's tumors.
Shing DC; McMullan DJ; Roberts P; Smith K; Chin SF; Nicholson J; Tillman RM; Ramani P; Cullinane C; Coleman N
Cancer Res; 2003 Aug; 63(15):4568-76. PubMed ID: 12907633
[TBL] [Abstract][Full Text] [Related]
20. Molecular detection of EWS-Ets fusion transcripts and their clinicopathologic significance in Ewing's sarcoma/peripheral primitive neuroectodermal tumor.
Wang H; Zheng J; Wang YP; Yang Y; You JF
Chin Med J (Engl); 2005 Aug; 118(16):1323-9. PubMed ID: 16157025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
